Aemetis Sees Unusually High Options Volume (NASDAQ:AMTX)

Key Points

• Investors bought 5,962 call options on Aemetis on Tuesday, an unusual spike of about 556% above the average call volume of 909, signaling elevated bullish options interest.
• Shares traded up 5.2% to $1.53; the company reported last quarterly results on Nov. 7 with EPS of ($0.37) missing estimates and revenue of $59.19M versus $87.79M expected, leaving Aemetis unprofitable with a negative P/E.
• Analyst views are mixed but skew positive—three Buys and one Sell give a consensus rating of "Moderate Buy" with a consensus target of $17—and institutional investors own about 27% of the stock, with firms like Vanguard and Goldman increasing positions.

Aemetis, Inc (NASDAQ:AMTX - Get Free Report) was the target of some unusual options trading on Tuesday. Investors bought 5,962 call options on the stock. This is an increase of approximately 556% compared to the average volume of 909 call options.

Aemetis Stock Up 5.2%

NASDAQ:AMTX traded up $0.08 during trading hours on Tuesday, hitting $1.53. 409,950 shares of the stock were exchanged, compared to its average volume of 754,375. The company has a market capitalization of $100.96 million, a P/E ratio of -0.94 and a beta of 2.31. The company's 50 day moving average is $1.53 and its two-hundred day moving average is $2.19. Aemetis has a twelve month low of $1.22 and a twelve month high of $3.66.

Aemetis (NASDAQ:AMTX - Get Free Report) last issued its quarterly earnings results on Friday, November 7th. The specialty chemicals company reported ($0.37) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.25) by ($0.12). The firm had revenue of $59.19 million during the quarter, compared to analyst estimates of $87.79 million. On average, equities research analysts expect that Aemetis will post -2.07 EPS for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on AMTX shares. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Aemetis in a report on Wednesday, January 21st. Ascendiant Capital Markets decreased their price objective on shares of Aemetis from $21.00 to $20.00 and set a "buy" rating on the stock in a research note on Wednesday, November 19th. Three analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $17.00.

Hedge Funds Weigh In On Aemetis

Several large investors have recently bought and sold shares of the business. Vanguard Group Inc. raised its holdings in shares of Aemetis by 15.3% during the third quarter. Vanguard Group Inc. now owns 2,479,163 shares of the specialty chemicals company's stock worth $5,578,000 after acquiring an additional 329,760 shares during the period. Jane Street Group LLC acquired a new position in shares of Aemetis during the 2nd quarter worth approximately $634,000. CIBC Bancorp USA Inc. bought a new stake in Aemetis in the 3rd quarter valued at $563,000. Goldman Sachs Group Inc. lifted its holdings in Aemetis by 71.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 218,404 shares of the specialty chemicals company's stock valued at $380,000 after purchasing an additional 91,367 shares during the last quarter. Finally, GSA Capital Partners LLP lifted its holdings in Aemetis by 42.4% during the 3rd quarter. GSA Capital Partners LLP now owns 179,790 shares of the specialty chemicals company's stock valued at $405,000 after purchasing an additional 53,508 shares during the last quarter. 27.02% of the stock is currently owned by institutional investors and hedge funds.

Aemetis Company Profile

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.